雷帕鸣哪里可以买

(sirolimus), as a new generation of immunosuppressant, has outstanding features such as little nephrotoxicity and anti-proliferative and anti-tumor effects. The application of sirolimus provides organ transplant recipients with the opportunity to replace CNI drugs, and thus has become a hot spot in clinical research in recent years.

In 1999, Rapamin was approved by the U.S. FDA and officially launched in the United States. It was not until 2002 that the drug was finally approved for domestic marketing, providing certain help in the treatment of many domestic kidney transplant patients. From that time on, patients can purchase the medicines they need at major hospitals and pharmacies in the country.

Another good news is that Leipamin has been included in the national medical insurance catalog and is a Class B drug. When patients purchase drugs, they can rely on medical insurance to reimburse part of the cost, thus achieving the purpose of reducing out-of-pocket expenses.

However, despite this, many patients are still unable to afford the drugs after medical insurance, so many domestic patients choose to purchase sirolimus overseas. Since the exchange rate floating price is not fixed, if patients want to know the specific price of sirolimus or want to purchase the drug overseas, they can consult with domestic reliable overseas medical service institutions (such as Medical Companion Travel).

Clinical studies have shown that the use of sirolimus (i.e. rapamin) can increase blood lipid levels. Excessive cholesterol in the blood causes a large amount of cholesterol to be deposited on the intima of the arteries, leading to arteriosclerosis and increased blood viscosity, further promoting the occurrence of arteriosclerosis and thrombosis. Hyperlipidemia can also promote the occurrence of chronic rejection of kidney transplants.

This reminds patients that there are certain medication risks during treatment. Although most adverse reactions can be controlled, patients need to pay high attention to those serious adverse reactions. Once symptoms worsen, patients should receive professional medical treatment immediately to prevent more serious safety incidents.

Recommended hot articles: /newsDetail/72822.html